Biotech News
Filter News
Found 495,488 articles
-
Middle East and Africa pharma economy to reach US$38.8bn by 2021
8/15/2018
CPhI MEA (Middle East and Africa) launches next month as favourable market conditions are driving increased growth across the Middle East and North Africa (MENA) pharma market – ageing and gentrifying populations, increased healthcare spending, and a modernising supply chain are transforming prospects in the region.
-
And now, this
6/20/2018
There are no words to describe and acknowledge this historic moment in Canada.
-
LUNGevity Foundation Kicks Off New Marketing Campaign to Raise Awareness of the Impact of Lung Cancer
6/13/2018
"234" asks the public to help change lung cancer statistics
-
Nicole Fevrier Davis Opens New MindBody Mastery Studio and Adds Psychic Assessments and Neurofeedback to her List of Unique Fitness Training Services
5/1/2018
Psychic personal trainer Nicole Fevrier Davis is slated to open her new studio at 10 Roberts Lane in Ridgefield CT on May 2nd.
-
Following AbbVie Lawsuit, Government Scrutinizes Industry-Provided Drug Educational Support Services
9/21/2018
A federal investigation is underway into whether or not the nursing and other medical services provided by some pharmaceutical companies to doctor’s offices actually violate the law due to serving an illegal commercial service. -
Incidence of Alzheimer’s disease is projected to double in the next 40 years unless a cure or preventive measures are found. The U.S. Centers for Disease Control and Prevention published a new report in the journal Alzheimer’s & Dementia projecting the disease’s likely expansion, and for the firs...
-
Bay Area’s uBiome Secures $83 Million as It Moves into Drug Development, Taps ex-Novartis CEO for...
9/21/2018
San Francisco-based uBiome snagged $83 million in a Series C financing round and also tapped industry veteran Joe Jimenez, the former chief executive officer of Swiss pharma giant Novartis, to its board of directors. -
Tokyo-based Astellas Pharma announced that its roxadustat met its primary endpoints in the Phase III ALPS clinical trial in chronic kidney disease (CKD) patients with anemia not on dialysis. The focus of the drug is on anemia.
-
In the biotech hub area known as Pharm Country, the small state of Rhode Island often gets overlooked in favor of its larger neighbors, such as New York, New Jersey and Pennsylvania. But, the Ocean State is making some moves to enhance its image as a biotech hub, particularly in the wake of some ...
-
As federal lawmakers continue to wrangle over legislation to help curb the opioid crisis in the United States, the House of Representatives is showing some division over the costs that some pharmaceutical companies may have to pay for Medicare coverage.
-
In September 2016, the U.S. FDA approved Sarepta Therapeutics’ eteplirsen, now marketed as Exondys 51, for Duchenne muscular dystrophy (DMD). And now, two years later, the European Medicines Agency (EMA) has rejected Sarepta’s application for Exondys 51.
-
September 21 Research Roundup: Zombie Cells, Pancreatic Cancer, Household Cleaners and Obesity, a...
9/21/2018
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
Shares of Acadia Pharmaceuticals soared more than 26 percent in trading on Thursday and continue to climb this morning in premarket trading after the U.S. Food and Drug Administration affirmed the safety profile of the company’s lead drug, Nuplazid.
-
Release: AbbVie Announces $5 Million Donation to Family Reach to Support Children Battling Cance...
9/21/2018
AbbVie, a research-based global biopharmaceutical company, today announced a donation of $5 million to Family Reach to support the organization’s efforts to alleviate the financial burden of cancer on pediatric patients and families across the United States. -
New York-based Y-mAbs Therapeutics will look at securing $96 million through an initial public offering to support development of its antibody-based therapeutic treatments for cancer.
-
Louder than a Lion: ROAR Organic Reaches Millennials with 100% Natural Beverage
9/21/2018
Roly Nesi, Founder and CEO of ROAR Organic, is a young entrepreneur with an eye for success in the beverage industry. In just 16 months, ROAR Organic has sold over 8 million bottles, with their first ever account being the Facebook NYC Offices.
-
Rafael Holdings to Present at Sidoti Fall 2018 Investor Conference
9/21/2018
Rafael Holdings, Inc. (NYSE American: RFL) today announced that its Chief Financial Officer, David Polinsky, will present an overview of the Company's business and strategy at the Sidoti & Company Fall 2018 Investor Conference. The presentation will begin at 1:30 PM Eastern on Thursday, September 27, 2018.
-
AlloSource Named One Of The 100 Healthiest Workplaces In America By Healthiest Employers
9/21/2018
AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced that Healthiest Employers® named AlloSource one of the 100 Healthiest Workplaces in America.
-
AARP Pushes Back on PhRMA's Attempts to Change Medicare Part D Doughnut Hole Deal
9/21/2018
AARP Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond released the following statement in response to lobbying efforts by PhRMA to change the Medicare Part D doughnut hole deal
-
New Tool Can Help Patients and Family Caregivers Get, Use, and Share Health Records
9/21/2018
Each year, hundreds of thousands of patients request copies of their medical records under the Health Insurance Portability and Accountability Act (HIPAA), the nation's privacy law.